Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?Lübeck Ralf Paus, W. Westerhof, Teresa Lambe et al.|Experimental Dermatology|2008Cited by 210
Immunohistochemistry as a potential tool for routine detection of the NRAS Q61R mutation in patients with metastatic melanomaMarius Ilié, Paul Hofman, Élodie Long-Mira et al.|Journal of the American Academy of Dermatology|2015Cited by 38
Dermatoscopic and clinical features of congenital or congenital-type nail matrix nevi: A multicenter prospective cohort study by the International Dermoscopy SocietyFélix Pham, L. Thomas, Amélie Boespflug et al.|Journal of the American Academy of Dermatology|2022Cited by 24
MelBase, constitution et suivi d’une cohorte nationale de patients atteints de mélanome stade III inopérable ou stade IV avec collection d’une base de données clinico-biologiquesClara Allayous, C. Lebbé, Laetitia Da Meda et al.|Annales de Dermatologie et de Vénéréologie|2014Cited by 3
Follow-up of a French national cohort of melanoma stage IV and unresectable stage III patients, MelBase.Clara Allayous, Célèste Lebbé, Stéphane Dalle et al.|Journal of Clinical Oncology|2015Cited by 1